NIH Funding Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
Notice NOT-AA-21-020 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:18:31 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Core (U24) (Clinical Trial Not Allowed)
Notice NOT-AA-21-021 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:18:36 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Core (U24 Clinical Trial Not Allowed)
Notice NOT-AA-21-022 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:18:41 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Core (U24 Clinical Trial Not Allowed)
Notice NOT-AA-21-023 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:18:45 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
Notice NOT-AA-21-024 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:18:49 EST

Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)"
Notice NOT-AA-21-025 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 01:43:59 EST

Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)"
Notice NOT-AA-21-026 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 01:53:35 EST

Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
Notice NOT-AA-21-027 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 02:01:28 EST

Request for Information (RFI): Research Challenges and Needs in Developing Chronomedicine for Health and Diseases
Notice NOT-CA-21-042 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 04:15:42 EST

Notice of Special Interest (NOSI): Telehealth in Cancer Care
Notice NOT-CA-21-043 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 12:53:39 EST

Updated NCI Guidance Concerning the Mentored Clinical Scientist Research Career Development Award: Percent Effort of Surgeon-Scientists for K08 awards from NCI
Notice NOT-CA-21-054 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 12:58:25 EST

Notice of Special Interest (NOSI): Administrative Supplement for Modifiable Factors Potentially affecting the Cost of Cancer Treatment
Notice NOT-CA-21-055 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 12:59:11 EST

Notice of Change: Receipt date added for RFA-EB-20-002, "BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Notice NOT-EB-21-006 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 12:19:05 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
Notice NOT-HG-21-027 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 12:41:24 EST

Notice of Special Interest (NOSI): Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences
Notice NOT-OD-21-079 from the NIH Guide for Grants and Contracts
Mon, 12 Apr 2021 10:50:16 EST

Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
Notice NOT-OD-21-101 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 05:19:36 EST

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)
Notice NOT-OD-21-103 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 05:19:34 EST

Reminder: Required use of FORMS-F application forms for application submission
Notice NOT-OD-21-104 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 11:55:55 EST

Notice of Clarification of Resubmission Due dates for RFA-RM-21-012, Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Notice NOT-RM-21-024 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 11:01:43 EST

Notice of Pre-Application Webinar for Funding Opportunities on Transformative Research to Address Health Disparities and Advance Health Equity
Notice NOT-RM-21-025 from the NIH Guide for Grants and Contracts
Mon, 12 Apr 2021 10:11:06 EST

Notice of Addition of Requested Institutional Information for RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions
Notice NOT-RM-21-026 from the NIH Guide for Grants and Contracts
Tue, 13 Apr 2021 11:52:29 EST

Notice of Special Interest (NOSI): Topic Areas for PAR-21-203, Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
Notice NOT-TR-21-025 from the NIH Guide for Grants and Contracts
Wed, 14 Apr 2021 01:12:16 EST

3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-21-037 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) as a part of its Beau Biden Cancer Moonshot Initiative invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP) as Recommendation I: Generation of Human Tumor Atlases. The overarching goal of this FOA is to accelerate research efforts conducted and led by the Human Tumor Atlas Network (HTAN, humantumoratlas.org) via the implementation of three-dimensional (3D) imaging technologies that will allow for a comprehensive view of the dynamic multidimensional ecosystems that define tumors in humans. Each project will lead to the multiplexed 3D characterization of at least one cancer transition investigated by the HTAN (pre-malignant to malignant, primary to metastatic, therapy responsive to resistant). The data and analytical tools generated through this FOA will be made available for use by the research and clinical communities through the activities of the HTAN Data Coordinating Center.
Wed, 14 Apr 2021 02:15:39 EST

Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-22-013 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement (FOA) is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; developing junior scientists; and maximizing the efficiency of research support.
Tue, 13 Apr 2021 01:22:17 EST

Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-22-014 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Programs.
Tue, 13 Apr 2021 11:34:24 EST

Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
Funding Opportunity RFA-MD-21-007 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support comprehensive research centers on prevention, treatment, and management of multiple chronic diseases associated with associated with health disparities.
Wed, 14 Apr 2021 12:37:16 EST

NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-MD-21-008 from the NIH Guide for Grants and Contracts. NIMHD invites applications from eligible institutions to establish a Research Coordinating Center (RCC) to support comprehensive research centers on prevention, treatment, and management of co-occurring chronic diseases associated with health disparities. The RCC will coordinate activities across all of the chronic disease centers, including data collection; promoting collaboration and communication among investigators and the broader research community; promoting skills development of early stage investigators; coordinating and managing in-person and/or virtual meetings; and facilitating community engagement efforts.
Wed, 14 Apr 2021 12:37:20 EST

Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)
Funding Opportunity RFA-OD-21-008 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADx-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.
Tue, 13 Apr 2021 05:19:31 EST

Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
Funding Opportunity RFA-OD-21-009 from the NIH Guide for Grants and Contracts. High rates and disparities of COVID-19 infection and mortality continue among underserved and vulnerable populations across the United States. The overarching goal of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative is to understand and ameliorate factors that have placed a disproportionate burden of the pandemic on underserved and/or vulnerable populations, specifically by implementing programs that expand the scope and reach of COVID-19 testing interventions to reduce these disparities. To address barriers to testing and vaccination, social, ethical, and behavioral research is urgently needed to inform related efforts. The purpose of this Phase II RADx-UP Funding Opportunity Announcement (FOA) is to expand research to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing interventions among underserved and vulnerable populations. Proposed studies for Phase II are encouraged to move beyond descriptive health disparities research to focus on developing interventions and other actionable solutions in collaboration with community partners and stakeholders. The funding for this initiative is provided from the. American Rescue Plan Act of 2021.
Tue, 13 Apr 2021 05:19:38 EST

Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-159 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from qualified research institutions to seek funds to develop or renovate research facilities that support HIV/AIDS research in areas of basic, translational, clinical, and social and behavioral science research. Targeted are institutions that serve underrepresented and underserved populations or that are in Institutional Development Award (IDeA)-eligible states. Research-intensive institutions are not eligible. The facilities must support research aligned with the NIH-established priorities for HIV/AIDS research. Any request must be justified by current and anticipated future research needs.
Mon, 12 Apr 2021 12:29:32 EST